The approved FDA indication for the aprevo Cervical ACDF System is: For use in skeletally mature patients with degenerative cervical conditions including cervical disc degeneration, stenosis, deformity, and/or instability of the cervical spine (C2-T1) at one or more levels
No large-scale human trials have evaluated combination protocols, so effects remain investigational
Although extremely rare, hydroxocobalamin injections can also cause serious side effects such as a major allergic reaction or irregular heartbeats (palpitations)
braille or large print
Prescription forms of levocarnitine were approved by the FDA in 1985 (tablets), 1986 (oral solution), and 1992 (injection) Reviews There are no reviews yet.
Vitamin B12 Supplements & Other Treatment Options If a blood test confirms a deficiency, Vitamin B12 supplements can help restore healthy levels